Clinical Trial Update: A Study to Investigate the Pharmacodynamic Effects of CT327 on Intra-dermal Nerve Growth Factor (NGF) and Evoked Pain Responses, in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacodynamic effects of CT327 on intra-dermal nerve growth factor and evoked pain responses in healthy male volunteers. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• CT327

Snippet

Sponsor: Creabilis SA | Conditions: Neuropathic Pain | Phase 1 | Status: COMPLETED